Skip to main content
Top
Published in: Acta Diabetologica 1/2012

01-12-2012 | Original Article

Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients

Authors: Luciane B. Ceretta, Gislaine Z. Réus, Helena M. Abelaira, Luciano K. Jornada, Magada T. Schwalm, Neiva J. Hoepers, Cristiane D. Tomazzi, Karina G. Gulbis, Renan A. Ceretta, João Quevedo

Published in: Acta Diabetologica | Special Issue 1/2012

Login to get access

Abstract

This study evaluated the association of mood disorders, suicidal ideation and the quality of life in patients with type 2 diabetes. We used a case–control study employing 996 patients suffering with type 2 diabetes (using insulin for over 1 year), and 2.145 individuals without diabetes. The groups were then used to evaluate the presence of different mood disorders and suicidal ideation, beyond quality of life. In addition to this, fasting glucose and glycosylated hemoglobin (Hb1C) were also evaluated. The data were analyzed using the Pearson chi-squared test, logistic regression, ANCOVA and Student’s t-tests. We showed an association between type 2 diabetes and depressive episodes (adjusted OR = 1.8, CI 95 % 1.7–2.0, p < 0.001), recurrent depressive episodes (adjusted OR = 2.4, CI 95 % 2.2–2.6, p < 0.001), dysthymia (adjusted OR = 5.2, CI 95 % 4.9–5.5, p < 0.001), mood disorder with psychotic symptoms (adjusted OR = 2.5, CI 95 % 1.5–3.4, p < 0.001) and suicidal ideation (adjusted OR = 3.6, CI 95 % 2.5–4.8, p < 0.001, light; adjusted OR = 4.6, CI 95 % 1.5–7.7, p < 0.01, moderate and severe). The recurrent depression (OR = 1.3, CI 95 % 1.1–1.7, p < 0.05) and psychotic symptoms (OR = 4.1, CI 95 % 1.1–15.1, p < 0.05) were associated with higher levels of Hb1C. Dysthymia was associated with high blood glucose (OR = 1.6, CI 95 % 1.1–2.5, p < 0.05). Patients had lower mean scores in the following domains: physical [36.5 (13.6) × 56.0 (4.9), p < 0.001)], psychological [42.6 (8.6) × 47.9 (8.6), p < 0.001] and environmental [40.0 (8.6) × 49.3 (8.3), p < 0.001], but had higher scores in the area of social relations [50.2 (16.9) × 35.7 (27.9), p < 0.001]. The data demonstrated a worse quality of life, a high comorbidity of type 2 DM with depressive disorders and suicidal ideation. In addition, the poor control of DM is associated with the severity of mood disorders.
Literature
1.
go back to reference King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21(9):1414–1431PubMedCrossRef King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21(9):1414–1431PubMedCrossRef
2.
go back to reference Giuffrida FM, Reis AF (2005) Genetic and clinical characteristics of maturity onset diabetes of the young. Diabetes Obes Metab 7(4):318–326PubMedCrossRef Giuffrida FM, Reis AF (2005) Genetic and clinical characteristics of maturity onset diabetes of the young. Diabetes Obes Metab 7(4):318–326PubMedCrossRef
3.
go back to reference Robles GI, Singh-Franco D (2009) A review of exenatide as djunctive therapy in patients with type 2 diabetes. Drug Des Devel Ther 21(3):219–240CrossRef Robles GI, Singh-Franco D (2009) A review of exenatide as djunctive therapy in patients with type 2 diabetes. Drug Des Devel Ther 21(3):219–240CrossRef
4.
go back to reference Srinivasan M, Bhagra S (2007) Diabetes and mortality risk after acute coronary syndromes. J Am Med Assoc 298(20):2367 Srinivasan M, Bhagra S (2007) Diabetes and mortality risk after acute coronary syndromes. J Am Med Assoc 298(20):2367
5.
go back to reference Egede LE, Simpson K (2003) Epidemiology, treatment and costs of depression in adults with Type 2 diabetes. Expert Rev Pharmacoecon Outcomes Res 3(3):251–262PubMedCrossRef Egede LE, Simpson K (2003) Epidemiology, treatment and costs of depression in adults with Type 2 diabetes. Expert Rev Pharmacoecon Outcomes Res 3(3):251–262PubMedCrossRef
6.
go back to reference Pouwer F, Kupper N, Adriaanse MC (2010) Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med 9(45):112–118PubMed Pouwer F, Kupper N, Adriaanse MC (2010) Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med 9(45):112–118PubMed
7.
go back to reference Knol M, Twisk J, Beekman A, Heine R, Snoek F, Pouwer F (2006) Depression as a risk factor for the onset of type 2 diabetes: a meta-analysis. Diabetologia 49(5):837–845PubMedCrossRef Knol M, Twisk J, Beekman A, Heine R, Snoek F, Pouwer F (2006) Depression as a risk factor for the onset of type 2 diabetes: a meta-analysis. Diabetologia 49(5):837–845PubMedCrossRef
8.
go back to reference Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23(11):1165–1173PubMedCrossRef Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23(11):1165–1173PubMedCrossRef
9.
go back to reference Barnard KD, Skinner TC, Peveler R (2006) The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet Med 23(4):445–448PubMedCrossRef Barnard KD, Skinner TC, Peveler R (2006) The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet Med 23(4):445–448PubMedCrossRef
10.
go back to reference Ceretta LB, Réus GZ, Abelaira HM, Ribeiro KF, Zappellini G, Felisbino FF, Steckert AV, Dal-Pizzol F, Quevedo J (2012) Antioxidant enzymes in the brains of alloxan-induced diabetic rats. Exp Diabetes Res 2012:302682PubMedCrossRef Ceretta LB, Réus GZ, Abelaira HM, Ribeiro KF, Zappellini G, Felisbino FF, Steckert AV, Dal-Pizzol F, Quevedo J (2012) Antioxidant enzymes in the brains of alloxan-induced diabetic rats. Exp Diabetes Res 2012:302682PubMedCrossRef
11.
go back to reference Ceretta LB, Réus GZ, Scaini G, Streck EL, Quevedo J (2010) Brain energy metabolism parameters in an animal model of diabetes. Metab Brain Dis 25(4):391–396PubMedCrossRef Ceretta LB, Réus GZ, Scaini G, Streck EL, Quevedo J (2010) Brain energy metabolism parameters in an animal model of diabetes. Metab Brain Dis 25(4):391–396PubMedCrossRef
12.
go back to reference Ceretta LB, Réus GZ, Stringari RB, Ribeiro KF, Zappellini G, Aguiar BW, Pfaffenseller B, Lersh C, Kapczinski F, Quevedo J (2012) Imipramine treatment reverses depressive-like behavior in alloxan-diabetic rats. Diabetes Metab Res Rev 28(2):139–144PubMedCrossRef Ceretta LB, Réus GZ, Stringari RB, Ribeiro KF, Zappellini G, Aguiar BW, Pfaffenseller B, Lersh C, Kapczinski F, Quevedo J (2012) Imipramine treatment reverses depressive-like behavior in alloxan-diabetic rats. Diabetes Metab Res Rev 28(2):139–144PubMedCrossRef
13.
go back to reference Nishikawa T, Araki E (2007) Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 9(3):343–353PubMedCrossRef Nishikawa T, Araki E (2007) Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 9(3):343–353PubMedCrossRef
14.
go back to reference Yorek MA (2003) The role of oxidative stress in diabetic vascular and neural disease. Free Radical Res 37(5):471–480CrossRef Yorek MA (2003) The role of oxidative stress in diabetic vascular and neural disease. Free Radical Res 37(5):471–480CrossRef
15.
go back to reference Krabbe KS, Nielsen AR, Krogh-Madsen R et al (2006) Brain-derived neurotropic factor (BDNF) and type 2 diabetes. Diabetologia 50(2):431–438PubMedCrossRef Krabbe KS, Nielsen AR, Krogh-Madsen R et al (2006) Brain-derived neurotropic factor (BDNF) and type 2 diabetes. Diabetologia 50(2):431–438PubMedCrossRef
16.
go back to reference Réus GZ, Abelaira HM, Stringari RB, Fries GR, Kapczinski F, Quevedo J (2012) Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. Metab Brain Dis 27(2):175–182PubMedCrossRef Réus GZ, Abelaira HM, Stringari RB, Fries GR, Kapczinski F, Quevedo J (2012) Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. Metab Brain Dis 27(2):175–182PubMedCrossRef
17.
go back to reference Abelaira HM, Réus GZ, Ribeiro KF, Zappellini G, Ferreira GK, Gomes LM, Carvalho-Silva M, Luciano TF, Marques SO, Streck EL, Souza CT, Quevedo J (2011) Effects of acute and chronic treatment elicited by lamotrigine on behavior, energy metabolism, neurotrophins and signaling cascades in rats. Neurochem Int 59(8):1163–1174PubMedCrossRef Abelaira HM, Réus GZ, Ribeiro KF, Zappellini G, Ferreira GK, Gomes LM, Carvalho-Silva M, Luciano TF, Marques SO, Streck EL, Souza CT, Quevedo J (2011) Effects of acute and chronic treatment elicited by lamotrigine on behavior, energy metabolism, neurotrophins and signaling cascades in rats. Neurochem Int 59(8):1163–1174PubMedCrossRef
18.
go back to reference de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a metaanalysis. Psychosom Med 63(4):619–630PubMed de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a metaanalysis. Psychosom Med 63(4):619–630PubMed
19.
go back to reference Egede LE, Nietert PJ, Zheng D (2005) Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 28(6):1339–1345PubMedCrossRef Egede LE, Nietert PJ, Zheng D (2005) Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 28(6):1339–1345PubMedCrossRef
20.
go back to reference Lustman PJ, Clouse RE (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 19(2):113–122PubMed Lustman PJ, Clouse RE (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 19(2):113–122PubMed
21.
go back to reference Bot M, Pouwer F, Ormel J, Slaets JPS, de Jonge P (2010) Original article: education and psychological aspects predictors of incident major depression in diabetic outpatients with subthreshold depression. Diabet Med 27(11):1295–1301PubMedCrossRef Bot M, Pouwer F, Ormel J, Slaets JPS, de Jonge P (2010) Original article: education and psychological aspects predictors of incident major depression in diabetic outpatients with subthreshold depression. Diabet Med 27(11):1295–1301PubMedCrossRef
22.
go back to reference Khazaie H, Rahimi M, Tatari F, Rezaei M, Najafi F, Tahmasian M (2011) Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram? Neurosciences 16(1):42–45PubMed Khazaie H, Rahimi M, Tatari F, Rezaei M, Najafi F, Tahmasian M (2011) Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram? Neurosciences 16(1):42–45PubMed
23.
go back to reference Ceretta LB, Réus GZ, Stringari RB, Ribeiro KF, Zappellini G, Aguiar BW, Pfaffenseller B, Lersh C, Kapczinski F, Quevedo J (2012) Imipramine treatment reverses depressive-like behaviour and increases brain-derived neurotrophic factor protein levels in the prefrontal cortex in diabetic rats. Diabetes Metab Res Rev 28(2):139–144PubMedCrossRef Ceretta LB, Réus GZ, Stringari RB, Ribeiro KF, Zappellini G, Aguiar BW, Pfaffenseller B, Lersh C, Kapczinski F, Quevedo J (2012) Imipramine treatment reverses depressive-like behaviour and increases brain-derived neurotrophic factor protein levels in the prefrontal cortex in diabetic rats. Diabetes Metab Res Rev 28(2):139–144PubMedCrossRef
24.
go back to reference Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV (2002) Increased prevalence of type 2 diabetes mellitus among psychiatric in patients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 70(1):19–26PubMedCrossRef Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV (2002) Increased prevalence of type 2 diabetes mellitus among psychiatric in patients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 70(1):19–26PubMedCrossRef
25.
go back to reference Zanuso S, Balducci S, Jimenez A (2009) Physical activity, a key factor to quality of life in type 2 diabetic patients. Diabetes Metab Res Rev 1:24–28CrossRef Zanuso S, Balducci S, Jimenez A (2009) Physical activity, a key factor to quality of life in type 2 diabetic patients. Diabetes Metab Res Rev 1:24–28CrossRef
26.
go back to reference Amorim P (2000) Mini International Neropsychiatric Interview(MINI): validação de entrevista breve para os transtornos mentais. Revista Brasileira de Psiquiatria 22:106–115CrossRef Amorim P (2000) Mini International Neropsychiatric Interview(MINI): validação de entrevista breve para os transtornos mentais. Revista Brasileira de Psiquiatria 22:106–115CrossRef
27.
go back to reference Fleck MPA, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L et al (1999) Application of the Portuguese version of the instrument for the assessment of quality of life of the World Health Organization (WHOQOL-100). Revista de Saúde Pública 33(2):198–205PubMedCrossRef Fleck MPA, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L et al (1999) Application of the Portuguese version of the instrument for the assessment of quality of life of the World Health Organization (WHOQOL-100). Revista de Saúde Pública 33(2):198–205PubMedCrossRef
28.
go back to reference Nau DP, Aikens JE, Pacholski AM (2007) Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus. Gend Med 4(3):205–213PubMedCrossRef Nau DP, Aikens JE, Pacholski AM (2007) Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus. Gend Med 4(3):205–213PubMedCrossRef
29.
go back to reference Trento M, Raballo M, Trevisan M, Sicuro J, Passera P, Cirio L, Charrier L, Cavallo F, Porta M (2012) A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol 49(3):199–203PubMedCrossRef Trento M, Raballo M, Trevisan M, Sicuro J, Passera P, Cirio L, Charrier L, Cavallo F, Porta M (2012) A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol 49(3):199–203PubMedCrossRef
30.
go back to reference Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control. Diabetes Care 237(7):934–942CrossRef Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control. Diabetes Care 237(7):934–942CrossRef
31.
go back to reference O’Connor PJ, Crain AL, Rush WA, Hanson AM, Fischer LR, Kluznik JC (2009) Does diabetes double the risk of depression? Ann Fam Med 74(4):328–335CrossRef O’Connor PJ, Crain AL, Rush WA, Hanson AM, Fischer LR, Kluznik JC (2009) Does diabetes double the risk of depression? Ann Fam Med 74(4):328–335CrossRef
32.
go back to reference Golden SH, Lazo M, Carnethon M et al (2008) Examining a bidirectional association between depressive symptoms and diabetes. J Am Med Assoc 299(23):2751–2759CrossRef Golden SH, Lazo M, Carnethon M et al (2008) Examining a bidirectional association between depressive symptoms and diabetes. J Am Med Assoc 299(23):2751–2759CrossRef
33.
go back to reference Kruse RL, Lemaster JW, Madsen RW (2010) Fall and balance outcomes after an intervention to promote leg strength, balance, and walking in people with diabetic peripheral neuropathy: “feet first” randomized controlled trial. Phys Ther 90(11):1568–1579PubMedCrossRef Kruse RL, Lemaster JW, Madsen RW (2010) Fall and balance outcomes after an intervention to promote leg strength, balance, and walking in people with diabetic peripheral neuropathy: “feet first” randomized controlled trial. Phys Ther 90(11):1568–1579PubMedCrossRef
34.
go back to reference Golden SH (2007) A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Curr Diabetes Rev 3(4):252–259PubMedCrossRef Golden SH (2007) A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Curr Diabetes Rev 3(4):252–259PubMedCrossRef
35.
go back to reference Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM (2003) Depression and coronary heart disease in women with diabetes. Psychosom Med 65(3):376–383PubMedCrossRef Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM (2003) Depression and coronary heart disease in women with diabetes. Psychosom Med 65(3):376–383PubMedCrossRef
36.
go back to reference Abramson J, Berger A, Krumholz HM, Vaccarino V (2001) Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 161(14):1725–1730PubMedCrossRef Abramson J, Berger A, Krumholz HM, Vaccarino V (2001) Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 161(14):1725–1730PubMedCrossRef
37.
go back to reference O’Neil A, Williams ED, Stevenson CE, Oldenburg B, Berk M, Sanderson K (2012) Co-morbid cardiovascular disease and depression: sequence of disease onset is linked to mental but not physical self-rated health. Results from a cross-sectional, population-based study. Soc Psychiatry Psychiatr Epidemiol 47:1145–1151 O’Neil A, Williams ED, Stevenson CE, Oldenburg B, Berk M, Sanderson K (2012) Co-morbid cardiovascular disease and depression: sequence of disease onset is linked to mental but not physical self-rated health. Results from a cross-sectional, population-based study. Soc Psychiatry Psychiatr Epidemiol 47:1145–1151
38.
go back to reference American Diabetes Association (2007) Clinical practice recommendations. Diabetes Care 1:S1–S103CrossRef American Diabetes Association (2007) Clinical practice recommendations. Diabetes Care 1:S1–S103CrossRef
39.
go back to reference Papelbaum M, Moreira RO, Coutinho W, Kupfer R, Zagury L, Freitas S, Appolinario JC (2011) Depression, glycemic control and type 2 diabetes. Diabetol Metab Syndr 3(1):26PubMedCrossRef Papelbaum M, Moreira RO, Coutinho W, Kupfer R, Zagury L, Freitas S, Appolinario JC (2011) Depression, glycemic control and type 2 diabetes. Diabetol Metab Syndr 3(1):26PubMedCrossRef
40.
go back to reference Manarte LF, Dias S, Góis C, Boavida JM (2010) Independent factors associated with depression in type 1 diabetes mellitus. Acta Diabetol 47(3):201–217PubMedCrossRef Manarte LF, Dias S, Góis C, Boavida JM (2010) Independent factors associated with depression in type 1 diabetes mellitus. Acta Diabetol 47(3):201–217PubMedCrossRef
41.
go back to reference Rotella F, Cresci B, Monami M, Aletti V, Andreoli V, Ambrosio ML, Ricca V, Dicembrini I, Mannucci E (2012). Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study. Acta Diabetologica. doi:10.1007/s00592-012-0403-4 Rotella F, Cresci B, Monami M, Aletti V, Andreoli V, Ambrosio ML, Ricca V, Dicembrini I, Mannucci E (2012). Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study. Acta Diabetologica. doi:10.​1007/​s00592-012-0403-4
42.
go back to reference Roy A, Roy M, Janal M (2010) Suicide attempts and ideation in African-American type 1 diabetic patients. Psychiatry Res 179(1):53–56PubMedCrossRef Roy A, Roy M, Janal M (2010) Suicide attempts and ideation in African-American type 1 diabetic patients. Psychiatry Res 179(1):53–56PubMedCrossRef
43.
go back to reference Pompili M, Pompili DL, Innamorati M, De Pisa E, Amore M, Ferrara C, Tatarelli R, Girardi P (2009) Quality of life and suicide risk. Psychosomatics 50(1):16–23PubMedCrossRef Pompili M, Pompili DL, Innamorati M, De Pisa E, Amore M, Ferrara C, Tatarelli R, Girardi P (2009) Quality of life and suicide risk. Psychosomatics 50(1):16–23PubMedCrossRef
44.
go back to reference IJzerman H, Schaper NC, Melai T, Meijer K, Willems PJB, Savelberg HHCM (2011) Lower extremity muscle strength is reduced in people with type 2 diabetes, with and without polyneuropathy, and is associated with impaired mobility and reduced quality of life T. Diabetes Res Clin Pract doi:10.1016/j.diabres.2011.10.026 IJzerman H, Schaper NC, Melai T, Meijer K, Willems PJB, Savelberg HHCM (2011) Lower extremity muscle strength is reduced in people with type 2 diabetes, with and without polyneuropathy, and is associated with impaired mobility and reduced quality of life T. Diabetes Res Clin Pract doi:10.​1016/​j.​diabres.​2011.​10.​026
45.
go back to reference Bello AI, Owusu-Boakye E, Adegoke BOA, Adjei DN (2011) Effects of aerobic exercise on selected physiological parameters and quality of lifein patients with type 2 diabetes mellitus. Int J Gen Med 4:723–727PubMed Bello AI, Owusu-Boakye E, Adegoke BOA, Adjei DN (2011) Effects of aerobic exercise on selected physiological parameters and quality of lifein patients with type 2 diabetes mellitus. Int J Gen Med 4:723–727PubMed
46.
go back to reference Forlani G, Nuccitelli C, Caselli C, Moscatiello S, Mazzotti A, Centis E, Marchesini G (2011). A psychological support program for individuals with Type 1 diabetes. Acta Diabetologica. doi:10.1007/s00592-011-0269-x Forlani G, Nuccitelli C, Caselli C, Moscatiello S, Mazzotti A, Centis E, Marchesini G (2011). A psychological support program for individuals with Type 1 diabetes. Acta Diabetologica. doi:10.​1007/​s00592-011-0269-x
47.
go back to reference Gois CJ, Ferro AC, Santos AL, Sousa FP, Ouakinin SR, do Carmo I, Barbosa AF (2010). Psychological adjustment to diabetes mellitus: highlighting self-integration and self-regulation. Acta Diabetologica. doi:10.1007/s00592-010-0191-7 Gois CJ, Ferro AC, Santos AL, Sousa FP, Ouakinin SR, do Carmo I, Barbosa AF (2010). Psychological adjustment to diabetes mellitus: highlighting self-integration and self-regulation. Acta Diabetologica. doi:10.​1007/​s00592-010-0191-7
48.
go back to reference Goodman E, Whitaker RC (2002) A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 110(3):497–504PubMedCrossRef Goodman E, Whitaker RC (2002) A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 110(3):497–504PubMedCrossRef
49.
go back to reference Andersohn F, Schade R, Suissa S, Garbe E (2009) Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 166(5):591–598PubMedCrossRef Andersohn F, Schade R, Suissa S, Garbe E (2009) Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 166(5):591–598PubMedCrossRef
50.
go back to reference Rao AA, Sridhar GR, Srinivas B, Das UM (2008) Bioinformatics analysis of functional protein sequences reveals a role for brain-derived neurotrophic factor in obesity and type 2 diabetes mellitus. Med Hypotheses 70(2):424–429PubMedCrossRef Rao AA, Sridhar GR, Srinivas B, Das UM (2008) Bioinformatics analysis of functional protein sequences reveals a role for brain-derived neurotrophic factor in obesity and type 2 diabetes mellitus. Med Hypotheses 70(2):424–429PubMedCrossRef
Metadata
Title
Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients
Authors
Luciane B. Ceretta
Gislaine Z. Réus
Helena M. Abelaira
Luciano K. Jornada
Magada T. Schwalm
Neiva J. Hoepers
Cristiane D. Tomazzi
Karina G. Gulbis
Renan A. Ceretta
João Quevedo
Publication date
01-12-2012
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue Special Issue 1/2012
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-012-0435-9

Other articles of this Special Issue 1/2012

Acta Diabetologica 1/2012 Go to the issue